Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Assay, Glycosylated Hemoglobin

FDA product code LCP · 238 cleared devices

Class 2 Hematology
Regulation
21 CFR 864.7470
Review panel
HE
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
1978-11-07 – 2024-11-22
↑